News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Firm News October 7, 2026
Gibson Dunn Advised Conflicts Committee of Board of Directors on $3 Billion Transformation of Hess Midstream LP
Gibson Dunn represented the Conflicts Committee of the board of directors in negotiating all aspects of the complex $3 billion independence transformation of Hess Midstream LP.
Accolades October 2, 2026
Lawdragon Names 29 Gibson Dunn Lawyers to 2027 List of 500 Leading Corporate Employment Lawyers
Lawdragon has named 29 Gibson Dunn lawyers to its 2027 list of 500 Leading Corporate Employment Lawyers – more than any other firm.
Firm News September 1, 2026
Gibson Dunn Advised Chobani on Acquisition of 1.5-Million-Square-Foot Manufacturing and Warehouse Campus
Gibson Dunn advised Chobani on the acquisition of a 1.5-million-square-foot manufacturing and warehouse campus in Allentown, Pennsylvania, and on the repurchase of Keurig Dr Pepper’s (KDP) equity stake.
Firm News June 11, 2026
Gibson Dunn Leads Groundbreaking SpaceX IPO
Gibson Dunn is serving as the lead counsel to Space Exploration Technologies Corp. (SpaceX) on its initial public offering and listing on Nasdaq and Nasdaq Texas.
Firm News February 24, 2026
Gibson Dunn Advises CECO Environmental on $2.2 Billion Strategic Combination with Thermon Group
Gibson Dunn is advising CECO Environmental Corp. on its $2.2 billion strategic combination with Thermon Group Holdings, Inc.
Article February 10, 2026
Columbia Law School Blog Reprints Gibson Dunn Client Alert
The Columbia Law School Blue Sky Blog — a blog on corporations and capital markets — has published the client alert “Gibson Dunn Discusses SEC Corporate-Finance Division’s Helpful Updates to Guidance,” authored by partners Mellissa Campbell Duru, Sebastian L. Fain, Gina Hancock, and Julia Lapitskaya and of counsel Rodrigo Surcan.
Firm News February 4, 2026
Gibson Dunn Advises Polaryx Therapeutics on Direct Listing on The Nasdaq Capital Market
Gibson Dunn represented Polaryx Therapeutics, Inc. in connection with its direct listing of shares of common stock on The Nasdaq Capital Market, where shares began trading under the ticker symbol "PLYX" on February 2, 2026.
Firm News February 3, 2026
Gibson Dunn Advised SpaceX on Acquisition of xAI
Gibson Dunn advised SpaceX on its acquisition of xAI.